Activation Of Protein Kinase A And Exchange Protein Directly Activated By Camp Promotes Adipocyte Differentiation Of Human Mesenchymal Stem Cells

Bingbing Jia,Lise Madsen,Rasmus Koefoed Petersen,Nathalie Techer,Reidun Kopperud,Tao Ma,Stein Ove Doskeland,Gerard Ailhaud,Jinfu Wang,Ez-Zoubir Amri,Karsten Kristiansen

DOI: https://doi.org/10.1371/journal.pone.0034114

IF: 3.7

2012-01-01

PLoS ONE

Abstract:Human mesenchymal stem cells are primary multipotent cells capable of differentiating into several cell types including adipocytes when cultured under defined in vitro conditions. In the present study we investigated the role of cAMP signaling and its downstream effectors, protein kinase A (PKA) and exchange protein directly activated by cAMP (Epac) in adipocyte conversion of human mesenchymal stem cells derived from adipose tissue (hMADS). We show that cAMP signaling involving the simultaneous activation of both PKA- and Epac-dependent signaling is critical for this process even in the presence of the strong adipogenic inducers insulin, dexamethasone, and rosiglitazone, thereby clearly distinguishing the hMADS cells from murine preadipocytes cell lines, where rosiglitazone together with dexamethasone and insulin strongly promotes adipocyte differentiation. We further show that prostaglandin I-2 (PGI(2)) may fully substitute for the cAMP-elevating agent isobutylmethylxanthine (IBMX). Moreover, selective activation of Epac-dependent signaling promoted adipocyte differentiation when the Rho-associated kinase (ROCK) was inhibited. Unlike the case for murine preadipocytes cell lines, long-chain fatty acids, like arachidonic acid, did not promote adipocyte differentiation of hMADS cells in the absence of a PPAR gamma agonist. However, prolonged treatment with the synthetic PPAR delta agonist L165041 promoted adipocyte differentiation of hMADS cells in the presence of IBMX. Taken together our results emphasize the need for cAMP signaling in concert with treatment with a PPAR gamma or PPAR delta agonist to secure efficient adipocyte differentiation of human hMADS mesenchymal stem cells.